Compare Lamb Weston Holdings Inc (LW) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lamb Weston Holdings Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Lamb Weston Holdings Inc trades at $49.45 (market cap $6.63B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Lamb Weston Holdings Inc is far larger — about 2.9× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Lamb Weston Holdings Inc pays a 3.16% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| LW | SLS | |
|---|---|---|
Market Cap | $6.63B | $2.28B |
Volume | 3,860,427 | 3,128,960 |
Sector | Consumer Staples | Health |
52-Week High | $66.57 | $15.46 |
52-Week Low | $38.48 | $1.39 |
Typical Hold Time | 66 Days | — |
Enterprise Value | $10.42B | $2.15B |
Dividend Yield | 3.16% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lamb Weston (LW) trades at $49.46, up 3.24% today, with a bullish technical signal and strong earnings beat history. The stock shows robust fundamentals with a P/E of 26.28 and ROE of 14.17%, supported by consistent revenue growth and positive cash flow trends. Recent news highlights cost savings exceeding $100M and upcoming Q1 earnings, while analyst consensus leans toward a hold with a $53.71 price target.
The outlook for LW is cautiously optimistic, with potential upside from margin recovery and earnings beats, but risks include profit margin volatility and legal scrutiny. Investors should weigh the stock's valuation against operational execution and market sentiment shifts ahead of earnings reports.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lamb Weston Holdings Inc
Lamb Weston is the world's second-largest producer of branded and private-label frozen potato products, such as French fries, sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. The company also has a small appetizer business that produces onion rings, mozzarella sticks, and cheese curds. Including joint ventures, 63% of fiscal 2022 revenue was U.S.-based, with the remainder stemming from Europe, Canada, Japan, China, Korea, Mexico, and several other countries. Lamb Weston's customer mix is estimated 58% quick-serve restaurants, 19% full-service restaurants, 8% other food services (hotels, commercial cafeterias, arenas, schools), and 16% retail. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
Read more on LW →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
